1 PET imaging of amyloid in Alzheimer's disease
来源:LANCET NEUROL( P 1474-4422 E 1474-4465 ) 发表时间: 2004/09
类型:期刊论文 为本人加分:73386.339745
2 Neuronal nicotinic receptors in the human brain
来源:PROG NEUROBIOL( P 0301-0082 E 1873-5118 ) 发表时间: 2000/05
类型:期刊论文 为本人加分:58286.811161
贡献度:单独通讯作者
3 Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications
来源:BIOL PSYCHIAT( P 0006-3223 E 1873-2402 ) 发表时间: 2001/02
类型:期刊论文,会议论文 为本人加分:40532.494976
4 The use of PET in Alzheimer disease
来源:NAT REV NEUROL( P 1759-4758 E 1759-4766 ) 发表时间: 2010/02
类型:期刊论文 为本人加分:37624.349179
5 PET imaging of amyloid deposition in patients with mild cognitive impairment
来源:NEUROBIOL AGING( P 0197-4580 E 1558-1497 ) 发表时间: 2008/10
类型:期刊论文 为本人加分:35805.736108
贡献度:单独通讯作者
6 Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
来源:BRAIN( P 0006-8950 E 1460-2156 ) 发表时间: 2006/11
类型:期刊论文 为本人加分:33878.593823
7 reduced number of [h-3] nicotine and [h-3] acetylcholine binding-sites in the frontal-cortex of alzh..
来源:NEUROSCI LETT( P 0304-3940 E ) 发表时间: 1986/12
类型:期刊论文 为本人加分:31555.741010
8 Cholinesterase inhibitors in the treatment of Alzheimer's disease - A comparison of tolerability..
来源:DRUG SAFETY( P 0114-5916 E 1179-1942 ) 发表时间: 1998/12
类型:期刊论文 为本人加分:28184.409842
9 Tau PET imaging in neurodegenerative tauopathies-still a challenge
来源:MOL PSYCHIATR( P 1359-4184 E 1476-5578 ) 发表时间: 2019/08
类型:期刊论文 为本人加分:26243.560392
10 neuroreceptor changes in alzheimer-disease
来源:CEREBROVAS BRAIN MET( P 1040-8827 E ) 发表时间: 1992/01
类型:期刊论文 为本人加分:24856.328400